In-patient treatment for severe COVID has come a long way since 2020 thanks, in part, to the rare opportunity of real-time data collection from so many people sick with the same disease at the same time. Dr. Brian Garibaldi, director of the Johns Hopkins Biocontainment Unit, returns to the podcast to talk with Stephanie Desmon about treating severely ill COVID patients, advances in therapeutics like antivirals and anti-inflammatory treatments, and why vaccines remain "the most astounding achievements."
